Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2013 August;104(4) > Minerva Medica 2013 August;104(4):391-411

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Share

 

  ACUTE CARDIAC CARE 

Minerva Medica 2013 August;104(4):391-411

Copyright © 2013 EDIZIONI MINERVA MEDICA

language: English

Reperfusion strategies in ST-segment elevation myocardial infarction

Stiermaier T., Desch S., Schuler G., Thiele H., Eitel I.

Unit of Cardiology Department of Internal Medicine, Heart Center University of Leipzig, Leipzig, Germany


PDF


ST-elevation myocardial infarction (STEMI) is a major cause of morbidity and mortality worldwide. Emergent reperfusion of the infarct related artery is the cornerstone of STEMI treatment in order to salvage myocardium and improve cardiovascular outcome. Basically, reperfusion strategies include fibrinolysis, primary percutaneous coronary intervention (PCI) or the combination of both methods. Clinical studies indicate that primary PCI is superior to fibrinolytic therapy when performed rapidly at experienced centers. However, physicians are often faced with the decision to either accept PCI-related delays due to transfer or to administer fibrinolysis immediately. A well structured regional system of STEMI care helps to select the appropriate reperfusion strategy and guarantee timely restoration of coronary blood flow. This article reviews the evidence behind the respective reperfusion therapies and summarizes current guidelines for STEMI management.

top of page